Glass Ceiling
Dark%20blue%20gradeint%20overlay_edited.

Leadership

Karyn O’Neil, PhD

Co-founder and Chief Scientific Officer

Karyn O’Neil, PhD, has more than 30 years of experience in peptide, antibody and protein engineering. As the Venture Leader for Centyrex, a Johnson & Johnson Venture, Karyn focused on designer protein platform technologies. She is co-inventor on the Centyrin patents and has led the team advancing the Centyrin platform since its inception. She joined Centocor/Johnson & Johnson in 2001 where, prior to working on Centyrins, she held positions of increasing responsibility, ultimately becoming a Director of Antibody Therapeutics. There she played a leadership role in the discovery and optimization of multiple clinical candidates. Prior to Johnson & Johnson, Karyn was in the Applied Biotechnologies group at DuPont Pharmaceuticals. Karyn received her PhD from the University of Pennsylvania where she focused on protein engineering and protein biophysics. She has authored more than 55 publications and holds over 30 patents. Karyn also serves as an editor for Protein Engineering, Design and Selection and sits on the SAB for Moulder Center for Drug Discovery Research.

Dark blue gradeint overlay Aro line two
  • Twitter
  • LinkedIn

Aro Biotherapeutics


3675 Market Street, Suite 200

Philadelphia, PA 19104

ARO-Logo-2018AUG29-V05-whiteF.png

© 2021 Aro Biotherapeutics Company. All Rights Reserved.